JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HEES
3526
DELISTED
H&E Equipment Services
HEES
| $3.63M | ﹤0.01% |
74,184
+46,105
| +164% | +$2.51M |
2015 Q4
36 quarters
|
|
3527
Kimco Realty Corp 7.25% Class N Preferred Stock
KIM.PRN
| $3.63M | ﹤0.01% |
60,430
+2,950
| +5% | +$181K |
2024 Q1
3 quarters
|
|
|
MRSN
3528
DELISTED
Mersana Therapeutics
MRSN
| $3.62M | ﹤0.01% |
101,378
+7,324
| +8% | +$379K |
2017 Q2
30 quarters
|
|
3529
CALL
Strategy Inc
MSTR
$63.8B
| $3.62M | ﹤0.01% |
+12,500
| New | +$3.76M |
2024 Q4
0 quarters
|
|
3530
Enel Chile
ENIC
$5.77B
| $3.62M | ﹤0.01% |
1,256,695
+451,482
| +56% | +$1.25M |
2023 Q2
6 quarters
|
|
3531
Ultrapar
UGP
$7.94B
| $3.62M | ﹤0.01% |
1,374,747
+1,215,605
| +764% | +$4.03M |
2013 Q2
46 quarters
|
|
|
NPKI
3532
NPK International
NPKI
$1B
| $3.61M | ﹤0.01% |
470,875
+102,466
| +28% | +$753K |
2016 Q4
32 quarters
|
|
3533
State Street SPDR Dow Jones REIT ETF
RWR
$1.77B
| $3.61M | ﹤0.01% |
36,515
-863
| -2% | -$89.9K |
2013 Q2
46 quarters
|
|
3534
CALL
Albemarle
ALB
$12.3B
| $3.61M | ﹤0.01% |
41,900
-1,800
| -4% | -$179K |
2021 Q2
14 quarters
|
|
3535
Midland States Bancorp
MSBI
$688M
| $3.6M | ﹤0.01% |
147,560
+37,254
| +34% | +$932K |
2016 Q3
33 quarters
|
|
3536
Oil States International
OIS
$496M
| $3.6M | ﹤0.01% |
710,669
+260,170
| +58% | +$1.3M |
2013 Q2
46 quarters
|
|
3537
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.21B
| $3.59M | ﹤0.01% |
147,959
+28,021
| +23% | +$710K |
2022 Q4
8 quarters
|
|
3538
Porch Group
PRCH
$1.97B
| $3.59M | ﹤0.01% |
730,340
+505,660
| +225% | +$1.62M |
2021 Q2
14 quarters
|
|
3539
Universal Insurance Holdings
UVE
$1.22B
| $3.59M | ﹤0.01% |
170,574
+23,325
| +16% | +$488K |
2015 Q1
39 quarters
|
|
3540
Amerant Bancorp
AMTB
$1.16B
| $3.59M | ﹤0.01% |
160,088
+136,827
| +588% | +$3.11M |
2019 Q1
23 quarters
|
|
3541
CALL
Chewy
CHWY
$7.3B
| $3.58M | ﹤0.01% |
107,000
+4,700
| +5% | +$146K |
2022 Q3
9 quarters
|
|
|
3542
PUT
Albemarle
ALB
$12.3B
| $3.58M | ﹤0.01% |
41,600
-600
| -1% | -$59.8K |
2022 Q4
8 quarters
|
|
3543
Ardmore Shipping
ASC
$788M
| $3.58M | ﹤0.01% |
294,408
-223,781
| -43% | -$3.04M |
2017 Q3
29 quarters
|
|
3544
Cognyte Software
CGNT
$645M
| $3.58M | ﹤0.01% |
413,448
+26,487
| +7% | +$200K |
2021 Q1
15 quarters
|
|
|
STKL
3545
DELISTED
SunOpta
STKL
| $3.57M | ﹤0.01% |
464,272
-50,898
| -10% | -$360K |
2017 Q2
30 quarters
|
|
3546
Brookdale Senior Living
BKD
$2.59B
| $3.57M | ﹤0.01% |
710,014
+505,569
| +247% | +$2.89M |
2013 Q2
46 quarters
|
|
3547
PUT
Zimmer Biomet
ZBH
$16.8B
| $3.57M | ﹤0.01% |
33,800
-5,500
| -14% | -$590K |
2023 Q4
4 quarters
|
|
3548
BioCryst Pharmaceuticals
BCRX
$2.09B
| $3.57M | ﹤0.01% |
474,376
-102,753
| -18% | -$780K |
2017 Q4
28 quarters
|
|
|
TRST
3549
Trustco Bank Corp NY
TRST
$948M
| $3.56M | ﹤0.01% |
107,008
+43,880
| +70% | +$1.53M |
2013 Q2
46 quarters
|
|
3550
Goldman Sachs BDC
GSBD
$1.02B
| $3.55M | ﹤0.01% |
293,491
+71,016
| +32% | +$932K |
2017 Q1
31 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.